EPZM
Epizyme, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Robert Bazemore
IPO Date
2013-05-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Epizyme, Inc.
CEO
Robert Bazemore
IPO Date
2013-05-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 8,994 |
| $0.00 |
| 16 Aug 2022 | GOLDFISCHER CARL | director | D-Return | Disposed | 3,380,951 | $1.45 |
| 16 Aug 2022 | MOTT DAVID M | director: | U-Tender | Disposed | 215,494 | $0.00 |
| 16 Aug 2022 | MOTT DAVID M | director | U-Tender | Disposed | 215,494 | $1.45 |
| 16 Aug 2022 | MOTT DAVID M | director | U-Tender | Disposed | 106,959 | $1.45 |
| 16 Aug 2022 | MOTT DAVID M | director: | D-Return | Disposed | 8,994 | $0.00 |
| 16 Aug 2022 | Bogle Grant C. | President and CEO | D-Return | Disposed | 84,170 | $0.00 |
| 16 Aug 2022 | Bogle Grant C. | director, officer: President and CEO | D-Return | Disposed | 84,170 | $1.45 |
| 16 Aug 2022 | Bogle Grant C. | director, officer: President and CEO | D-Return | Disposed | 175,000 | $0.00 |